Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomura International is the London-based investment banking arm of the Nomura Group, a leading global financial services provider headquartered in Japan. The firm is a significant player in the life sciences and healthcare sectors, offering specialized advisory services for mergers and acquisitions, equity capital markets, and debt financing. Nomura International is particularly recognized for its dedicated healthcare team, which supports biotechnology and pharmaceutical companies in navigating complex financial transactions and strategic growth. While not a drug developer itself, the company plays a crucial role in the biotech ecosystem by facilitating the capital flow and strategic partnerships necessary for medical innovation. The firm's expertise in the sector was significantly bolstered by the acquisition of Nomura Code Securities, a specialist healthcare investment bank, and its historical venture capital activities through Nomura Phase4 Ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nomura International.